BAC
Bank of America Corporation
BAC has the edge over HG overall, supported by stronger modeled upside and stronger valuation.
HG
Hamilton Insurance Group, Ltd.
HG's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
HG's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like HG.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
HG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.2x | $27.30 | -30% |
| Fair | 6.2x | $32.22 | -17% |
| Expensive | 6.8x | $35.17 | -9.2% |
| Current | 7.4x | $38.74 | — |
| Forward | 8.3x | $38.74 | — |
Historical ranges are pointers, not guarantees.
HG has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over HG on the outlook, with more favorable valuation and profitability expectations.
HG Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HG, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
HG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.67 | -10% |
| Q3 2026 | $5.21 | +23% |
| Q2 2026 | $5.72 | +57% |
| Q1 2026 | $6.09 | +99% |
| Q4 2025 | $5.55 | +51% |
HG has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over HG on profitability, with a higher operating margin.
HG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $828M | +24% |
| Q2 2026 | $839.6M | +13% |
| Q1 2026 | $758.9M | -1.3% |
| Q4 2025 | $728.3M | +28% |
| Q3 2025 | $667.7M | +30% |
| Q2 2025 | $740.8M | +26% |
| Q1 2025 | $768.8M | +17% |
| Q4 2024 | $570.5M | +15% |
HG's revenue is growing: $828M last quarter, up 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 27% | +0.4 points |
| Q2 2026 | 31% | -5.9 points |
| Q1 2026 | 29% | +4.9 points |
| Q4 2025 | 26% | +13 points |
| Q3 2025 | 27% | +15 points |
| Q2 2025 | 37% | +2 points |
| Q1 2025 | 24% | -18 points |
| Q4 2024 | 13% | -7 points |
HG's operating margin was 27% last quarter, about level with the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
HG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $267.2M | -9.6% |
| Q2 2026 | $125.3M | -43% |
| Q1 2026 | $100.8M | +189% |
| Q4 2025 | $293.4M | +3.3% |
| Q3 2025 | $295.6M | +84% |
| Q2 2025 | $218.4M | +40% |
| Q1 2025 | $34.9M | -78% |
| Q4 2024 | $284.1M | +701% |
HG has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HG on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -178K shares |
| 1 year | -3.5% | -3.7M shares |
| 3 years | -8.3% | -9.1M shares |
HG has 101M diluted shares, down 3.5% from a year ago, with $79M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.1M |
| Q2 2026 | $22.2M |
| Q1 2026 | $33.1M |
| Q4 2025 | $20.2M |
| Q3 2025 | $40.5M |
| Q2 2025 | $35M |
| Q1 2025 | $16.9M |
| Q4 2024 | $27M |
HG spent $79M buying back its own shares over the past year, down 34% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.1x | Net Cash |
| Q2 2025 | -1.4x | Net Cash |
| Q1 2025 | -1.3x | Net Cash |
| Q4 2024 | -1.3x | Net Cash |
HG has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 74.2 | Neutral |
HG's weekly RSI is 68 (neutral) and its Stochastic is 74 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
HG PE vs Financial Services Sector
| Metric | HG | Sector median | Relative |
|---|---|---|---|
| PE | 7.4x | 13x | 43% below |
| PE % | 100 | 40 | 60 pts above |
HG has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
HG has stronger trend alignment. BAC is above 1 of 5 weekly averages versus HG above 4 of 4.
HG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.7 | 8.7% above |
| 20 week MA | $35.4 | 9.3% above |
| 50 week MA | $32.0 | 21% above |
| 100 week MA | $26.8 | 45% above |
HG is in an uptrend: it's above all four of its weekly moving averages, and 45% above its 100-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
HG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $15.2 | $15.0 | -1.6% |
| 2024 | $15.0 | $18.7 | +25% |
| 2025 | $18.7 | $28.2 | +51% |
| 2026 YTD | $28.2 | $38.7 | +37% |
HG has the edge over BAC on returns for 2026, with the stronger performance.